- Welcome
- Abstracts
- Registration
- Session Submission Terms
- Hotels
- Programme
- Programme
- Programme Embed Test
- Programme
- Programme
- Programme
- Late Breaking Submissions
- EuroVeRsion Case Contest
- Abstract Submission
- Keynote Lectures
- General Information
- Social Media Toolkit
- Delegate Party
- Travel Details
- Women in Retina Networking Breakfast
- Membership Register Now Pay Later
- 2025 Press
- Sustainability Plan
- Satellite Symposia
- EURETINA IME Platform: Digital Visualisation IME Platform: Enhanced Precision and Outcomes in Retinal Surgery – From Innovation to Implementation
- EssilorLuxottica: Evolving Strategies in Myopia Management: New Perspectives and Evidence.
- Alcon: Achieving Superior Efficiency 1-4* in Vitreoretinal Surgery (1. Alcon Data on File, 2024. [REF-24644]; 2. Alcon Data on File, 2024. [REF-24379] 3. Alcon Data on File, 2024. [REF-24576]; 4. Alcon Data on File, 2024. [REF-24615])
- iCare: Advancing Retinal Imaging: Current Trends and Future Directions
- Lumibird Medical: Changing And Rethinking Vitreous And Retinal Treatments With Lasers
- Roche: THROUGH OUR PATIENTS’ EYES: Patient Voices in the Era of Continuous Drug Delivery for Retinal Disease
- Bayer: From Data to Decisions: What Do We See in the Real World?
- Roche: The nAMD Challenge: Looking Beyond VEGF-A Inhibition
- Roche: Real-World Decisions with Real-World Data
- Ora: Rethinking Retina: Building Smarter Clinical Trials for a Global Clinical Execution
- Bayer: Evolving Practice in Retinal Care: The Journey From Lab to Patient
- AbbVie: Spotlight on Inflammation: Evolving the Management of DME and RVO
- Heidelberg Engineering: Innovations in Imaging – Transforming Patient Care
- ZEISS Medical Technology: Illuminating Diabetic Retinopathy: Using Diagnostic Imaging and Advanced Surgical Visualization to Enhance Patient Care
- Ocular Therapeutix: Advancing Retinal Disease Treatment: Exploring OTX-TKI’s Potential to Extend Treatment Durability
- Bayer: The Time is Now: Lead the Way to Shape the Future
- Roche: The DME Challenge: Looking Beyond VEGF-A Inhibition
- Canon Medical Systems Europe: Beyond the Central Retina: The Impact of Ultra-Widefield OCT & OCT-A
- AbbVie: Updates in AI-driven OCT Biomarker Analysis to Optimise Treatment for DME and RVO
- NIDEK CO., LTD.: Diagnostic Pursuits Using Advanced Insights into Morphologic Changes in Chorioretinal Disease
- LumiThera, Inc.: Photobiomodulation Therapy for Dry AMD: Insights from 4.5 Years of Follow-up from the LIGHTSITE IIIB Trial
- 4D Molecular Therapeutics: Intravitreal Gene Therapy: A New Era of Durable Treatment for Retinal Vascular Diseases with 4D-150
- Astellas Pharma Inc.: Geographic Atrophy Patient Management: What Do You See? What Would You Do?
- Optos: Enhancing Patient Care Through Innovation: The Power of Ultra-widefield Imaging and Navigated Peripheral OCT
- TowardPi Medical: TowardPi! How 400kHz OCT/OCTA change practice
- Microclear Medical Instruments: SKY Launch, Odyssey From Retina To Cornea
- Amgen: Decoding Biosimilars and Biosimilar Development
- Espansione Group: Light Modulation™ LLLT (PBM): A New Frontier in Retinal Care & Beyond
- Roche: Advocating for Innovative Therapies: Everything You Need to Know
- Exhibitors & Sponsors
- FAQs
Block "168091" not found